MACOM (MTSI) Q2 2026 Earnings Transcript

MACOM reported fiscal Q2 revenue of $289 million, up 6.4% sequentially and more than 22% year over year, with adjusted EPS of $1.09 and adjusted operating income hitting a record $80.5 million. Management raised its Data Center full-year growth outlook to over 60% from 35%-40% and guided fiscal Q3 revenue to $331 million-$339 million with EPS of $1.31-$1.37, while gross margin is expected to improve to 59%-60%. The record 1.5:1 book-to-bill, strong backlog, and continued strength in Data Center and Defense point to further momentum, although some revenue from new optical and laser products remains more speculative.

Analysis

The key second-order signal is not just demand strength, but backlog quality: a record book-to-bill with a high share of orders that are contractable within 12 months suggests the company is moving from “design-win optionality” to visible revenue conversion. That matters because the business is now showing operating leverage without relying on a step-function in CapEx; gross margin expansion is being driven by utilization and yield, which should make consensus underwrite a less capital-intensive growth profile than peers in the optical/RF supply chain.

The market may still be underestimating how much of the Data Center upside is coming from portfolio breadth rather than a single socket. The company is simultaneously exposed to legacy optics, 800G/1.6T, coherent-light experimentation, equalization, and even a possible carryover benefit from DFB scarcity as competitors pivot away from older parts. That diversification reduces single-product risk and could keep growth elevated even if one subcycle pauses, but it also means the bull case is more durable than the typical “one hot product” rerate story.

The most important risk is timing, not demand. Several upside vectors are clearly pushed into FY27/FY28: CW lasers, LEO full-rate production, and any benefit from defense market share gains after competitor exits. If investors extrapolate the current growth rate too aggressively into the next two quarters, the stock can still stall on “show-me” execution around process qualification, supply continuity, and mix volatility, especially given the company’s own refusal to promise a clean ramp path.

Contrarianly, this may still be early for the longest-duration value creation. The company is using targeted investments and supply-chain partnerships to keep optionality inside existing fabs, which should support a higher terminal margin than the market likely assumes. The setup looks better for sustained multiple support than for a near-term blowoff: earnings revisions should keep rising, but the biggest price re-rate may wait until FY27 visibility improves and more of the latent product pipeline becomes billable.

Key Decisions for Investors

• Long MTSI into pullbacks over the next 2-6 weeks; the setup favors revision-driven upside, with downside limited by visible FY26 guide and backlog, but expect volatility around any component qualification updates.
• Pair long MTSI / short a slower-growth semiconductor analog or RF peer over 1-2 quarters; MTSI’s growth is more self-funded and less capex-heavy, while peers with weaker backlog conversion should lag if margins widen as expected.
• Buy MTSI Jan-2027 call spreads on any post-earnings consolidation; the risk/reward is better for FY27 optionality (LEO, CW lasers, defense share gains) than for chasing near-term continuation.
• If already long, trail-stop on a break of the next quarter’s margin guidance or any sign of working-capital inventory build beyond demand support; the bull case depends on conversion, not just bookings.
• Consider short-dated hedges via semiconductor ETF puts if holding a concentrated MTSI position; the stock’s upside is idiosyncratic, but macro semis multiple compression could otherwise mask fundamental outperformance.